Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Placebo in Bipolar I Mania
NCT00257075Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2000
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Risperidone with Placebo (2 arms). Primary endpoint: Young Mania Rating Scale at 3 weeks. Started Dec 2000; status: completed.
02
Drugs
risperidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00257075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257075.